Quick Summary
Covering the latest research from top Wall Street investment banks

Helium supply shock is manageable in the short term, with limited impact on semiconductors and MRI

Institution
UBS
Date
2026-04-02
Authors
Francois-Xavier Bouvignies, Geoff Haire, Graham Doyle, Harry Blaiklock, CFA, Kavya Deshpande, Thyra Lee, Joshua Spector, CFA
Company
-
Ticker
-
Industry
Chemicals
Rating
-
NeutralLow confidenceThe report argues that helium supply is tightening due to Middle East conflicts and the shutdown of Qatar-related supply, but semiconductor companies typically have inventories covering 2 to 6 months, and MRI manufacturers are protected by the shift toward low-helium or helium-free technology, so the near-term material impact is limited.
AuthorsFrancois-Xavier Bouvignies, Geoff Haire, Graham Doyle, Harry Blaiklock, CFA, Kavya Deshpande, Thyra Lee, Joshua Spector, CFA
CoverageUnited States
Business segmentsHelium supply chain、Industrial gases、Semiconductor manufacturing、Medical imaging、MRI equipment
Research firm divisions/subsidiariesUBS(Other)、UBS AG London Branch(Other)、UBS Securities LLC(Other)

AI summary card

Helium supply shock is manageable in the short term, with limited impact on semiconductors and MRI

UBS believes that, although about 30% of global helium supply has been affected by the Middle East conflict and the shutdown of Qatar LNG assets, inventories, supply prioritization, recycling technology, and low-helium MRI equipment will cushion the short-term impact.

Industry research; no unified industry rating or target price was provided. The report cites Siemens Healthineers as Neutral, Philips as Buy, and GE Healthcare as Sell.
Helium supplyIndustrial gasesSemiconductorsMRIMiddle East conflictSupply chain risk
  • The helium market has shifted from oversupply to undersupply, and the report says the closure of the Strait and the shutdown of Qatar LNG assets have taken about 30% of global helium supply offline.
  • In semiconductor manufacturing, helium can be replaced in some steps by nitrogen, argon, hydrogen, or forming gas, but replacement is difficult in wafer cooling and high-vacuum, high-heat scenarios.
  • Industry discussions suggest inventories typically cover 2 to 6 months; if the Middle East conflict lasts less than two months, the impact on semiconductors is expected to be limited.
  • MRI equipment relies on liquid helium to cool superconducting magnets, but modern systems can go years without refilling, and the spread of low-helium or helium-free technology reduces future risk.
  • The helium supply chain is highly concentrated, with industrial gas companies such as Air Products, Air Liquide, Linde, and Messer controlling refining, liquefaction, logistics, and customer deliveries.

Report interpretation

Overview

This report examines whether helium supply is facing a material problem and focuses on the impact on industrial gases, semiconductor manufacturing, and medical imaging equipment. It notes that the Middle East conflict disrupted Qatar-related helium supply, pushing the global helium market from oversupply into shortage; however, major producers have reserves, semiconductor companies have months of inventory and strategic supply priority, and MRI manufacturers are protected by equipment upgrades and low refill requirements, so the near-term impact is generally limited.

Core views

The core view is that helium is experiencing supply disruption, but in the short term it does not pose a systemic shock to key downstream users. In semiconductors, helium is important in wafer backside cooling, plasma etching/deposition, leak detection, and carrier/purge gas applications. Some uses can be substituted, but critical cooling steps remain difficult to replace; inventories typically cover 2 to 6 months, so if the conflict lasts less than two months, the impact is expected to be limited. In medical imaging, liquid helium is essential for MRI operation, but modern MRI systems can retain helium for years, routine maintenance usually does not require release or refill, and the industry is moving toward helium-free or low-helium equipment. In industrial gases, supply is highly concentrated, and reserve capacity and long-term contracts are key buffers against shocks.

Analysis framework

The report combines industry supply-demand analysis, regional capacity distribution, company supply-chain exposure, downstream application decomposition, and substitution feasibility assessment. Its judgment is based on discussions with industry participants and company representatives, media information, regional supply shares, the capabilities of major suppliers, the degree of helium dependence in semiconductor processes, and changes in MRI technology routes.

Methodology notes

  • Industry supply and demandAnalysis of regional helium supply and capacity shares

    Break down global helium supply concentration by region and major suppliers.

    The report compares the global helium supply landscape in 2025 and 2030, assessing changes in shares across North America, the Middle East, Eurasia, and Africa, as well as the importance of QatarEnergy, Gazprom, ExxonMobil, Sonatrach, Air Products, Linde, and others.

  • Supply chain riskInventory buffer and supply priority assessment

    Judge the impact of short-term supply disruption based on inventory months and strategic importance.

    The report believes corporate inventories typically cover 2 to 6 months, and leading semiconductor companies, with strong balance sheets and strategic importance, may receive priority in the helium supply chain.

  • Technology substitutionFeasibility analysis of semiconductor process substitution

    Differentiate between substitutable and hard-to-substitute steps.

    Nitrogen, argon, hydrogen, and forming gas can replace helium in some carrier gas, purge, plasma process, or leak detection applications, but wafer cooling and low-temperature high-vacuum scenarios still depend heavily on helium.

  • Valuation methodDCF, forward P/E, EV/EBITDA, and SOTP

    UBS typically uses discounted cash flow, forward price-to-earnings, EV/EBITDA, and sum-of-the-parts approaches for target prices on related stocks.

    The report states that target price formation considers organic sales growth, profitability, ROIC, cash conversion, and relative valuation premiums or discounts.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Linde
    Industrial gas supplier and helium distributor
    Strengths
    It has diversified sources and storage caverns in Texas; helium sales are more contract-based than spot-based, with a tendency to lock in long-term volumes for 3 to 5 years.
    Weaknesses
    Helium and rare gases are estimated to account for only 2% to 3% of total sales, limiting direct sensitivity.
    Comparison
    Compared with Air Products, Linde has lower exposure to helium sales; Air Products' exposure is about 7% to 8%.
    Risks
    If the global supply disruption lasts beyond inventory and reserve protection, customer deliveries and costs may still come under pressure.
  • Air Products
    Industrial gases and helium supply chain participant
    Strengths
    It has relatively high sales exposure to helium and rare gases and may benefit from tighter market pricing.
    Weaknesses
    Higher exposure also means greater sensitivity to supply disruptions and customer fulfillment risk.
    Comparison
    The report estimates its helium and rare gas sales exposure at about 7% to 8%, higher than Linde’s 2% to 3%.
    Risks
    Spot price volatility, supply interruptions, and long-term customer relationship management risk.
  • Air Liquide
    Major industrial gas company
    Strengths
    It participates in refining, liquefaction, logistics, and global customer delivery, placing it at the core of a highly concentrated supply chain.
    Weaknesses
    The report does not provide a specific helium revenue exposure figure.
    Comparison
    It is one of the frontline industrial gas companies dominating the supply chain, alongside Linde, Air Products, and Messer.
    Risks
    Helium supply concentration and limited price transparency could amplify supply shocks.
  • Messer
    Industrial gas company and entity related to Cliffside Field
    Strengths
    The report says Cliffside Field was sold to Messer in 2024, and this storage facility has historically been important for stabilizing the US and global helium market.
    Weaknesses
    The report does not disclose its commercial exposure or the scale of inventory availability.
    Comparison
    It, together with Air Products, Air Liquide, and Linde, forms the main group of industrial gas suppliers.
    Risks
    Commercial use of storage assets, policy changes, and supply-chain transparency risk.
  • Semiconductor companies
    Downstream demand for helium
    Strengths
    Inventories usually cover 2 to 6 months, leading companies have strong balance sheets and strategic importance, and may receive supply priority; some processes can substitute nitrogen, argon, or forming gas.
    Weaknesses
    Wafer backside cooling, high-heat and high-vacuum steps, and EUV-related cryogenic cooling are hard to replace.
    Comparison
    Compared with MRI, semiconductor manufacturing is more sensitive to process continuity and substitution validation.
    Risks
    If the supply interruption exceeds the inventory period, process tuning, yield, capacity, and delivery timelines may be affected.
  • Siemens Healthineers
    MRI manufacturer
    Strengths
    Modern MR equipment typically does not require helium refill during routine maintenance, and nearly 50% of new MR deliveries include helium-free magnets.
    Weaknesses
    MR accounts for about 20% of group revenue, indicating relatively high exposure to this technology segment.
    Comparison
    The MR revenue share is higher than the estimated exposure for Philips and GE Healthcare.
    Risks
    Extreme quench events may require helium replenishment.
  • Philips
    MRI manufacturer
    Strengths
    It launched the first helium-free MR in 2018; the report says all of its current 1.5T MR system orders are helium-free.
    Weaknesses
    The report estimates MR accounts for about 5% of group revenue, so there is still some medical imaging exposure.
    Comparison
    Its MR revenue share is lower than Siemens Healthineers'; rating is Buy.
    Risks
    If helium-free product deliveries or supply-chain conversion fall short of expectations, equipment installation and service may still be affected.
  • GE Healthcare
    MRI manufacturer
    Strengths
    Modern scanners can retain helium for years, and routine service may not require release and refill.
    Weaknesses
    The report estimates MR accounts for about 7% of group revenue, with a Sell rating.
    Comparison
    Its MR exposure is higher than Philips but lower than Siemens Healthineers.
    Risks
    The installed base of legacy equipment, customer service terms, and extreme refill needs may lead to cost volatility.

Key data

  • Global helium supply affectedAbout 30%The report says the closure of the Strait and the near-shutdown of Qatar LNG assets took about 30% of global helium supply offline.
  • Semiconductor inventory coverage2 to 6 monthsIndustry discussions indicate that inventory levels vary across companies and end markets, typically covering 2 to 6 months.
  • 2025 North America helium supply share47%North America is the largest supply region, and the United States alone accounts for more than 42% of global supply.
  • 2025 Middle East helium supply shareAbout 31% to 34%The text and chart use slightly different figures, but both show the Middle East as the second-largest supply region.
  • 2030 North America helium supply share forecast42%North America’s share is expected to decline as new capacity in other regions comes online.
  • 2030 Middle East helium supply share forecast34%This is mainly driven by the Qatar Ras Laffan 4 and 5 expansions.
  • Industrial gas companies' 2025 capacity controlMore than 67%Air Products, Air Liquide, Linde, and Messer collectively control more than 67% of global helium production capacity.
  • MRI share of global helium consumption14%In 2025, MRI is the largest single use of helium.
  • Semiconductor share of helium consumption19%The chart shows semiconductors as an important helium application area.
  • Medical imaging market sizeAbout $50 billionMRI is the second-largest subsegment of the medical imaging market, accounting for about 20% of the total market.
  • Siemens Healthineers MR revenue exposureAbout 20% of group revenueThe report lists SHL as Neutral.
  • Philips MR revenue exposureAbout 5% of group revenueThe report estimates that Philips MR revenue accounts for about 5% of the group, with a Buy rating.
  • GE Healthcare MR revenue exposureAbout 7% of group revenueThe report estimates that GE Healthcare MR revenue accounts for about 7% of the group, with a Sell rating.
  • Low-helium MRI usage7 liters or less than 0.5% of a traditional scannerThe report says recent helium-free MR systems use only a very small amount of helium and reduce losses over the equipment lifecycle.
  • Helium capture rate in advanced recycling systems80% to 90%Advanced wafer fabs can recover and reuse most of the helium.

Impact & implications

For investors, the helium supply disruption looks more like a short-term cost and delivery risk than an immediate collapse in demand for the semiconductor or medical imaging industries. The key issues to monitor are whether the supply interruption lasts beyond inventory buffers, whether the supply chain tilts toward strategic customers, whether industrial gas companies can maintain supply using reserves and long-term contracts, and whether low-helium technology and helium recycling can reduce long-term structural risk. If the conflict lasts longer, wafer cooling, EUV-related cooling, highly sensitive leak detection, and traditional MRI equipment could become pressure points.

Risks

  • The Middle East conflict lasts longer than two months, exhausting inventory buffers and increasing pressure on semiconductor supply chains.
  • Recovery of Qatar LNG and helium-related capacity is slower than expected, keeping global supply tight for longer.
  • The helium supply chain is concentrated in a few industrial gas companies and upstream producers, with limited transparency and oligopolistic characteristics.
  • Key semiconductor cooling steps are hard to substitute, and substitute gases may lead to insufficient heat transfer, process tuning, line delays, or yield risk.
  • Hydrogen, as a substitute, carries flammability risk, while nitrogen and argon face heat transfer and process compatibility limits in some scenarios.
  • Although MRI equipment is generally less affected, rare quench events can result in large helium losses and trigger refill needs.
  • Helium price volatility may be passed through to end customers via service contracts or customer terms, affecting procurement and maintenance costs.
  • Regional supply rebalancing before 2030 depends on new projects in Qatar, Gazprom, and Africa, and carries project execution and geopolitical uncertainty.

What to watch

  • Whether transportation risks related to the Middle East conflict and the Strait of Hormuz ease.
  • Progress in the recovery of Qatar Ras Laffan LNG and helium assets.
  • Inventory, reserves, and long-term contract commentary from industrial gas companies such as Linde, Air Products, Air Liquide, and Messer.
  • Whether semiconductor companies' helium inventory moves toward the low or high end of the 2 to 6 month range.
  • Adoption and actual recovery efficiency of helium recycling systems at leading wafer fabs.
  • Progress in validating nitrogen, argon, forming gas, and other substitutes in mass-production processes.
  • The share of helium-free or low-helium MRI in new orders for Siemens Healthineers, Philips, and GE Healthcare.
  • Changes in the global regional helium supply mix through 2030, especially new capacity in the Middle East, Russia, South Africa, and Tanzania.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins